While SBRT has been used on low and intermediate risk patients since 2003, its efficacy on high risk patients has not yet been established. My friend Lupron Jim has recently been treated with this modality, as has another man in my support group. There are many details of treatment that remain to be resolved, but based on convenience, cost and lack of toxicity, it is poised to take the lead as the new "gold standard" for high risk men.
I encourage men with access to any of the few clinical trials to enquire about
it with the investigators. You can read more about
them at the following link:
SBRT for high-risk prostate cancer- Allen